Latest News from: Thomas Jefferson University

Filters close
Released: 17-Sep-2012 8:00 AM EDT
Thomas Jefferson University Hospitals and the Eagles Team Up for Prostate Health and Cancer Awareness
Thomas Jefferson University

September is Prostate Cancer Awareness month, and Thomas Jefferson University Hospitals has again teamed up with the Philadelphia Eagles to educate fans and others about prostate health and to raise cancer awareness.

Released: 10-Sep-2012 8:00 AM EDT
Physician's Empathy Directly Associated with Positive Clinical Outcomes, a Large Study of Italian Diabetic Patients Confirms
Thomas Jefferson University

Patients of doctors who are more empathic have better outcomes and fewer complications, concludes a large, empirical study by a team of Thomas Jefferson University and Italian researchers who evaluated relationships between physician empathy and clinical outcomes among 20,961 diabetic patients and 242 physicians in Italy.

Released: 5-Sep-2012 9:05 AM EDT
Chair of Surgery, Charles Yeo, M.D., Performs 500th Whipple Procedure at Thomas Jefferson University Hospital
Thomas Jefferson University

Charles J. Yeo, MD, FACS, Chair of Surgery, and a co-director of the Jefferson Pancreas, Biliary and Related Cancer Center, performed his 500th Whipple procedure at Jefferson. To date, Dr. Yeo has performed 1,144 Whipple procedures.

Released: 5-Sep-2012 8:55 AM EDT
Voichita Bar-Ad, M.D., Named Residency Program Director in Jefferson’s Radiation Oncology Department
Thomas Jefferson University

Voichita Bar-Ad, M.D., an associate professor in the Department of Radiation Oncology at Thomas Jefferson University Hospital, has been named Residency Program Director.

Released: 1-Aug-2012 9:50 AM EDT
Thomas Jefferson University Renames its Graduate School
Thomas Jefferson University

The Jefferson College of Graduate Studies has been renamed the Jefferson Graduate School of Biomedical Sciences (JGSBS) to better reflect the school’s breadth of degrees and programs and overall mission.

Released: 27-Jul-2012 9:05 AM EDT
Breast Cancer Patients Who Lack RB Gene Respond Better to Neoadjuvant Chemotherapy
Thomas Jefferson University

Breast cancer patients whose tumors lacked the retinoblastoma tumor suppressor gene (RB) had an improved pathological response to neoadjuvant chemotherapy, researchers at Thomas Jefferson University Hospital and the Kimmel Cancer Center at Jefferson report in a retrospective study published in a recent online issue of Clinical Cancer Research.

Released: 5-Jul-2012 12:15 PM EDT
Jefferson Hospital Performs First Robot-Assisted Distal Pancreatectomy
Thomas Jefferson University

Minimally invasive procedure to remove part of pancreas offers a shorter hospital stay and faster recovery.

Released: 14-Jun-2012 4:00 PM EDT
How Aging Normal Cells Fuel Tumor Growth and Metastasis
Thomas Jefferson University

Researchers at the Kimmel Cancer Center at Jefferson have shown that senescence (aging cells which lose their ability to divide) and autophagy (self-eating or self-cannibalism) in the surrounding normal cells of a tumor are essentially two sides of the same coin, acting as “food” to fuel cancer cell growth and metastasis.

Released: 6-Jun-2012 2:25 PM EDT
HIV Drug May Slow Down Metastatic Breast Cancer
Thomas Jefferson University

The HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing, researchers from the Kimmel Cancer Center at Jefferson suggest in a preclinical study published in a recent issue of Cancer Research.

Released: 17-May-2012 4:45 PM EDT
Jefferson’s Kimmel Cancer Center to Host Tribute Dinner Honoring Steve Sabol, President of NFL Films
Thomas Jefferson University

For demonstrating great strength and dignity through a battle with brain cancer, Mr. Sabol will be honored with the Spirit of Courage Award.

Released: 16-May-2012 2:40 PM EDT
Jefferson Receives $2.6 Million NIH Grant to Study Imaging Method to Stage Prostate Cancer Without Biopsy
Thomas Jefferson University

Jefferson’s Kimmel Cancer Center and the Department of Radiology at Thomas Jefferson University received a five-year, $2.6 million grant from the National Institutes of Health (NIH) to investigate a potentially revolutionary method that can stage prostate cancers and detect recurrent disease so accurately, it would significantly reduce the number of confirmation biopsies.

Released: 14-May-2012 8:00 AM EDT
Thomas Jefferson University Hospital Creates Comprehensive Hepatitis C Center
Thomas Jefferson University

Jefferson Hepatitis C Center tailored to treat rising population for “silent killer. ”

Released: 2-May-2012 11:05 AM EDT
Nanobiotix and Thomas Jefferson University Start Research Collaboration
Thomas Jefferson University

Nanomedicine and Medical Education leaders are joining their forces in the United States to accelerate the development of NanoXray.

Released: 1-May-2012 3:45 PM EDT
Rothman Institute at Jefferson Spine Surgeons Recognized Among the Best in the Country
Thomas Jefferson University

Surgeons at the Rothman Institute at Jefferson were recently voted by their peers as three of the top 28 spine surgeons in the country. The complete list appears on the popular industry website, Orthopedics This Week (http://ryortho.com/).

Released: 30-Apr-2012 12:25 PM EDT
Poorer Quality of Life for Gay Men and Minorities After Prostate Cancer Treatment: What Are We Missing?
Thomas Jefferson University

To improve the quality of life in gay men and minorities treated for prostate cancer, a greater awareness of ethnic and sexual preference-related factors is needed to help men choose a more-suitable treatment plan, researchers from Thomas Jefferson University Hospital conclude in a literature review published May 1 in Nature Reviews Urology.

Released: 26-Apr-2012 1:30 PM EDT
Thomas Jefferson University's Scott Waldman Awarded CURE Grant to Move Colon Cancer Test Closer to Commercialization
Thomas Jefferson University

Scott Waldman, M.D., Ph.D., Chair of the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University, has been awarded a Commonwealth Universal Research Enhancement (CURE) grant for almost $750,000 to help advance a molecular diagnostic test for colon cancer into commercialization.

17-Apr-2012 9:55 AM EDT
Thomas Jefferson University Hospital Cardiologists Educate Internists
Thomas Jefferson University

(NEW ORLEANS) – Howard Weitz, M.D., FACP, FACC, director of the division of Cardiology and the Jefferson Heart Institute at Thomas Jefferson University Hospital, and Bernard L. Segal Professor of Medicine at Jefferson Medical College of Thomas Jefferson University and his colleagues will again lead a pre-course session, Cardiology for the Internist, at the American College of Physicians’ Internal Medicine 2012 in New Orleans. The session will educate internists on the diagnostic, preventative and therapeutic approaches to the patient at risk for or with known cardiovascular disease.

Released: 12-Apr-2012 2:15 PM EDT
Thomas Jefferson University Hospital Opens New Barrett’s Esophagus Treatment CenterOne of Few Dedicated Barrett’s Centers in the U.S.
Thomas Jefferson University

Thomas Jefferson University Hospital announces the opening of its new Jefferson Barrett’s Esophagus Treatment Center, one of only a few dedicated Barrett’s centers in the country and the first multidisciplinary center solely dedicated to treating Barrett’s esophagus disease in Philadelphia.

Released: 5-Apr-2012 4:00 PM EDT
Edith Mitchell, M.D., FACP, Named 2012 Recipient of ASCO Humanitarian Award
Thomas Jefferson University

Edith Mitchell, M.D., FACP, a medical oncologist at Jefferson’s Kimmel Cancer Center, has been named the 2012 recipient of the American Society of Clinical Oncology Humanitarian Award for her personification of the society’s mission and values, and for going above and beyond the call of duty in providing outstanding patient care.

Released: 3-Apr-2012 2:50 PM EDT
Eliminating the ‘Good Cholesterol’ Receptor May Fight Breast Cancer
Thomas Jefferson University

Study suggests SR-BI plays a role in breast cancer tumor growth, say Jefferson’s Kimmel Cancer Center researchers.

Released: 3-Apr-2012 2:45 PM EDT
New Biomarker to Identify Hepatitis B-Infected Patients at Risk for Liver Cancer
Thomas Jefferson University

Hepatitis B-infected patients with significantly longer telomeres—the caps on the end of chromosomes that protect our genetic data— were found to have an increased risk of getting liver cancer compared to those with shorter ones, according to findings presented by researchers at Jefferson’s Kimmel Cancer Center at the American Association for Cancer Research Annual Meeting 2012.

Released: 30-Mar-2012 3:15 PM EDT
Post-Surgery Walking Program Significantly Improves Fatigue and Quality of Life in Pancreatic Cancer Patients
Thomas Jefferson University

Participation in a home walking program can lead to a significant improvement in quality of life, fatigue levels and physical functioning of post-surgery pancreatic cancer patients, according to findings from a randomized, controlled study by researchers at Thomas Jefferson University and Jefferson School of Nursing – set to appear in the Journal of the American College of Surgeons on April 1.

Released: 26-Mar-2012 2:55 PM EDT
New Brachytherapy Suite Opens at Jefferson’s Kimmel Cancer Center
Thomas Jefferson University

Thomas Jefferson University Hospital’s Department of Radiation Oncology has unveiled the region’s only image-guided brachytherapy suite, where patients can have radiation imaging, planning and treatment in a single location without being moved.

22-Mar-2012 8:00 AM EDT
Carotid Artery Stenting Found to Be Safe in the Elderly
Thomas Jefferson University

Researchers at Thomas Jefferson University Hospital in Philadelphia and a multicenter team of investigators have found that carotid artery stenting (CAS) is safe and effective in patients age 70 and older.

22-Mar-2012 3:15 PM EDT
Complicating Tears during Coronary Angioplasty: Where are they Most Prevalent and how do They Affect Patient Outcomes?
Thomas Jefferson University

Researchers from Thomas Jefferson University Hospital discovered that blockages in the right coronary artery and those in bending areas of the coronary artery are the most common places for coronary dissection, a tear in the artery that can occur during balloon angioplasty of the coronary arteries.

14-Mar-2012 12:40 PM EDT
Cancer Paradigm Shift: Biomarker Links Clinical Outcome with New Model of Lethal Tumor Metabolism
Thomas Jefferson University

Researchers at the Kimmel Cancer Center at Jefferson have demonstrated for the first time that the metabolic biomarker MCT4 directly links clinical outcomes with a new model of tumor metabolism that has patients “feeding” their cancer cells. Their findings were published online March 15 in Cell Cycle.

Released: 13-Mar-2012 5:00 PM EDT
Jefferson’s ARCHES Project Wins National Hospital Charitable Service Award; Receives $10,000 Grant
Thomas Jefferson University

The ARCHES Project, a program of Thomas Jefferson University Hospitals, was one of 10 programs from across the country named a Program of Excellence by the Hospital Charitable Service Awards, a national program sponsored by Jackson Healthcare.

Released: 8-Mar-2012 3:50 PM EST
Thomas Jefferson University Hospital Oncologists and Surgeons Treating More Colorectal Cancer Patients Under 50
Thomas Jefferson University

Jefferson physicians are seeing a growing trend of more colorectal cancer patients under 50, some even under 40, said Scott D. Goldstein, M.D., Director of the Division of Colorectal Surgery at Thomas Jefferson University Hospital

Released: 6-Mar-2012 5:30 PM EST
Decompression Surgery Performed Less than 24 Hours After Traumatic Cervical Spinal Cord Injury Leads to Improved Outcomes for Patients
Thomas Jefferson University

Researchers at the Rothman Institute at Jefferson have shown that patients who receive surgery less than 24 hours after a traumatic cervical spine injury suffer less neural tissue destruction and improved clinical outcomes. The results of their study, the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS) are available in PLoS One.

Released: 28-Feb-2012 8:00 AM EST
Jefferson Researchers Discover Meditation has Positive Effects on Mood and Anxiety in Patients with Memory Loss
Thomas Jefferson University

Researchers at Thomas Jefferson University Hospital determined that mantra-based meditation can have a positive impact on emotional responses to stress, fatigue and anxiety in adults with memory impairment and memory loss. Their findings are published in the recent issue of the Journal of Alternative and Complementary Medicine.

Released: 27-Feb-2012 6:00 PM EST
A New Battlefront: Symposium at Jefferson’s Kimmel Cancer Center to Tackle Geriatric Oncology
Thomas Jefferson University

National thought leaders in geriatric oncology will gather at a unique symposium at the Kimmel Cancer Center at Jefferson in Philadelphia on Friday, March 9, 2012, where they will present an overview of the latest advances in the understanding and treatment of cancer in older adults in an effort to impact patient care.

Released: 23-Feb-2012 4:30 PM EST
Empathy Difficult for Medical Students to Maintain; Creates Model to Improve and Sustain Students’ Empathy
Thomas Jefferson University

New findings of a follow-up to landmark Jefferson study showing physician's empathy directly associated with positive clinical outcomes.

20-Feb-2012 9:05 AM EST
Stronger Intestinal Barrier May Prevent Cancer in the Rest of the Body, New Study Suggests
Thomas Jefferson University

Thomas Jefferson University researchers found that silencing hormone receptor weakens intestinal barrier, making body more susceptible to cancer.

Released: 16-Feb-2012 12:10 PM EST
Jefferson’s Kimmel Cancer Center Establishes Center to Eliminate Cancer Disparities
Thomas Jefferson University

In an effort to reduce and eventually eliminate cancer disparities among adults in the Philadelphia region, the Kimmel Cancer Center at Jefferson has established the Center to Eliminate Cancer Disparities.

Released: 15-Feb-2012 4:00 PM EST
Taxpayers Give Back for Cancer: Thomas Jefferson University Researcher Awarded ‘Refunds for Research’ Grant
Thomas Jefferson University

Takemi Tanaka, Ph.D., of Thomas Jefferson University’s School of Pharmacy and the Kimmel Cancer Center, received a $50,000 grant toward her breast cancer research, as part of the Pennsylvania Breast Cancer Coalition’s “Refunds for Breast and Cervical Cancer Research” initiative.

Released: 14-Feb-2012 2:00 PM EST
Jefferson Heart Attack Patient Embraces Second Chance
Thomas Jefferson University

After he failed to heed the first big warning about his heart, John Magri was lucky to survive the second. Magri’s first heart attack at age 46 didn’t faze him much. He didn’t follow his doctor’s orders to start to eat a healthier and to quit smoking. Moreover, the South Jersey-man took his medication, a blood thinner necessary to prevent the coronary stent he got after the first heart attack from becoming blocked, only sporadically. A second heart attack in January – just a year and a half after the first – got Magri’s attention. He is lucky to be alive and knows it.

Released: 10-Feb-2012 9:05 AM EST
Curry Spice Component May Help Slow Prostate Tumor Growth
Thomas Jefferson University

Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy, a study from researchers at Jefferson’s Kimmel Cancer Center suggests.

7-Feb-2012 5:05 PM EST
Local Anesthesia May be More Beneficial in Managing Pain vs. Opioids Following Knee Replacement Surgery
Thomas Jefferson University

Researchers at the Rothman Institute at Jefferson have shown that local anesthesia delivered through a catheter in the joint, intraarticularly, may be more beneficial than traditional opioids such as morphine and Oxycontin for pain management following total knee replacement surgery.

3-Feb-2012 4:30 PM EST
Researchers Suggest Abandoning Convention in Diagnosis of Periprosthetic Joint Infection
Thomas Jefferson University

In their search for new, better ways to diagnose periprosthetic joint infection, Rothman Institute at Jefferson researchers have shown that the accepted method of diagnosis, measuring a patients’ serum white blood cell count (WBC) and the percentage of neutrophils (PMN%) in the synovial fluid, has a minimal role in the determination of PJI.

Released: 7-Feb-2012 4:30 PM EST
Researchers Find Epidural Steroid Injections Do Not Benefit Spine Patients
Thomas Jefferson University

(PHILADELPHIA) – Researchers at the Rothman Institute at Jefferson examined data on patients being treated for lumbar stenosis and the degenerative spine condition spondylolisthesis and found that patients who received epidural steroid injections (ESI) had a higher rate of crossover to surgery and fared worse in physical health and bodily pain versus those who did not receive ESI, dispelling their pre-study hypothesis.

3-Feb-2012 4:30 PM EST
Researchers Suggest New Test in Diagnosing Periprosthetic Joint Infection (PJI)
Thomas Jefferson University

Rothman Institute at Jefferson joint researchers continue to seek better ways to diagnose and subsequently treat periprosthetic joint infection (PJI) in patients following total joint arthroplasty. Their latest research shows leukocyte esterase reagent (LE) strips, common in diagnosing urinary tract infections, can also have a role in rapid diagnosis of PJI.

2-Feb-2012 10:00 AM EST
Drugs Targeting Chromosomal Instability May Fight A Particular Breast Cancer Subtype
Thomas Jefferson University

Researchers at Kimmel Cancer Center at Jefferson show that cyclin D1 overexpression associates with chromosomal instability in luminal B breast cancer.

Released: 25-Jan-2012 4:00 PM EST
Brachytherapy Reduced Death Rates in High-Risk Prostate Cancer Patients
Thomas Jefferson University

A population-based analysis looking at almost 13,000 cases revealed that men who received brachytherapy alone or in combination with external beam radiation therapy had significantly reduced mortality rates.

Released: 25-Jan-2012 3:00 PM EST
Jefferson Emergency Department Staff Volunteers at General Clinic in Sierra Leone; Aim to Improve Healthcare Delivery
Thomas Jefferson University

On Sunday, January 29, three physicians and two nurses from the Thomas Jefferson University Hospital Emergency Department (ED) will travel to Sierra Leone to help improve the quality of healthcare and its delivery within the impoverished West African country. The Jefferson physicians will stay for two weeks and the nurses for six weeks. This will be the second trip for Jefferson’s team in a little more than a year.

Released: 24-Jan-2012 8:50 AM EST
New Jefferson Lung Cancer Screening Program Builds on Latest Research for Early Diagnosis
Thomas Jefferson University

Lung cancer, the leading cause of cancer deaths in the U.S. and worldwide, is often caught too late. Thomas Jefferson University Hospital experts in pulmonary and critical care, radiology, thoracic surgery, and medical and radiation oncology have teamed up to launch a novel effort to screen, diagnose and treat lung cancer in its earliest stages.

Released: 17-Jan-2012 5:25 PM EST
Jefferson-Myrna Brind Center of Integrative Medicine Launches Integrative Pediatrics Program
Thomas Jefferson University

Integrative medicine, the field of medicine which combines the use of conventional and complementary techniques in reaching health and wellness goals, is now available for pediatric patients through the Integrative Pediatrics program at the Jefferson-Myrna Brind Center of Integrative Medicine. Under the guidance of a board-certified pediatrician, the program combines the best evidence-based conventional medicine with a variety of proven lifestyle therapies and complementary techniques for pediatric patients from birth through 21 years.

Released: 13-Jan-2012 1:00 PM EST
Study Shows Allergy to Plavix Can Be Overcome
Thomas Jefferson University

Allergies to Plavix®, also know by its chemical name, Clopidogrel occur in about six percent of patients given the drug, vital for the prevention of life-threatening stent thrombosis after angioplasty and percutaneous coronary interventions. Researchers at Thomas Jefferson University found that a combination of steroids and antihistamines can successfully alleviate the allergic reaction and enable patients to remain on the drug. Until now, hypersensitivity required drug interruption, placing the patient at risk for restenosis or a major coronary event.

Released: 13-Jan-2012 9:30 AM EST
Thomas Jefferson University Hospital Earns Bariatric Surgery Program Center of Excellence Accreditation
Thomas Jefferson University

Thomas Jefferson University Hospital’s Bariatric Surgery Program, along with David Tichansky, M.D., F.A.C.S., the program director, have been awarded a full three-year accreditation by the American Society of Metabolic and Bariatric Surgery (ASMBS) Bariatric Surgery Center of Excellence, one of the field’s highest levels of recognition.

Released: 12-Jan-2012 10:30 AM EST
Cabazitaxel with Radiation and Hormone Therapy May Improve Prostate Cancer Survival
Thomas Jefferson University

Kimmel Cancer Center at Jefferson begins multimodality Phase I trial with next “major advance in chemotherapy for advanced prostate cancer.”



close
0.22967